Global Influenza Virus Vaccine (H1N1) Market Research Report 2025(Status and Outlook)
Report Overview
Influenza Virus Vaccine (H1N1), which is specifically designed to protect against the a (H1N1) virus, previously known as swine flu.
The global Influenza Virus Vaccine (H1N1) market size was estimated at USD 8250.42 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Influenza Virus Vaccine (H1N1) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Influenza Virus Vaccine (H1N1) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Influenza Virus Vaccine (H1N1) market
Global Influenza Virus Vaccine (H1N1) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL
NVS(Novartis)
Sanofi Pasteur
Medimmune
GSK
Baxter
Beijing Kexing Bio-Vaccine
Hualan Bio-Vaccine
Changchun Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Jiangsu Yanshen Bio-Technology
Zhejiang Tianyuan Bio-Pharmaceutical
Dalian Yalifeng Bio-Pharmaceutical
Sinopharm
Market Segmentation (by Type)
Intramuscular Vaccine
Nasal Spray Vaccine
Market Segmentation (by Application)
3 To 10 Years Old
10 To 18 Years Old
Above 18 Years Old
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Virus Vaccine (H1N1) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Influenza Virus Vaccine (H1N1), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Influenza Virus Vaccine (H1N1), which is specifically designed to protect against the a (H1N1) virus, previously known as swine flu.
The global Influenza Virus Vaccine (H1N1) market size was estimated at USD 8250.42 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Influenza Virus Vaccine (H1N1) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Influenza Virus Vaccine (H1N1) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Influenza Virus Vaccine (H1N1) market
Global Influenza Virus Vaccine (H1N1) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL
NVS(Novartis)
Sanofi Pasteur
Medimmune
GSK
Baxter
Beijing Kexing Bio-Vaccine
Hualan Bio-Vaccine
Changchun Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Jiangsu Yanshen Bio-Technology
Zhejiang Tianyuan Bio-Pharmaceutical
Dalian Yalifeng Bio-Pharmaceutical
Sinopharm
Market Segmentation (by Type)
Intramuscular Vaccine
Nasal Spray Vaccine
Market Segmentation (by Application)
3 To 10 Years Old
10 To 18 Years Old
Above 18 Years Old
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Influenza Virus Vaccine (H1N1) Market
- Overview of the regional outlook of the Influenza Virus Vaccine (H1N1) Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Virus Vaccine (H1N1) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Influenza Virus Vaccine (H1N1), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Influenza Virus Vaccine (H1N1)
1.2 Key Market Segments
1.2.1 Influenza Virus Vaccine (H1N1) Segment by Type
1.2.2 Influenza Virus Vaccine (H1N1) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA VIRUS VACCINE (H1N1) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Virus Vaccine (H1N1) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Influenza Virus Vaccine (H1N1) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA VIRUS VACCINE (H1N1) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Influenza Virus Vaccine (H1N1) Product Life Cycle
3.3 Global Influenza Virus Vaccine (H1N1) Sales by Manufacturers (2020-2025)
3.4 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza Virus Vaccine (H1N1) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Influenza Virus Vaccine (H1N1) Market Competitive Situation and Trends
3.8.1 Influenza Virus Vaccine (H1N1) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza Virus Vaccine (H1N1) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFLUENZA VIRUS VACCINE (H1N1) INDUSTRY CHAIN ANALYSIS
4.1 Influenza Virus Vaccine (H1N1) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA VIRUS VACCINE (H1N1) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza Virus Vaccine (H1N1) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Influenza Virus Vaccine (H1N1) Market
5.7 ESG Ratings of Leading Companies
6 INFLUENZA VIRUS VACCINE (H1N1) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2020-2025)
6.3 Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Type (2020-2025)
6.4 Global Influenza Virus Vaccine (H1N1) Price by Type (2020-2025)
7 INFLUENZA VIRUS VACCINE (H1N1) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Virus Vaccine (H1N1) Market Sales by Application (2020-2025)
7.3 Global Influenza Virus Vaccine (H1N1) Market Size (M USD) by Application (2020-2025)
7.4 Global Influenza Virus Vaccine (H1N1) Sales Growth Rate by Application (2020-2025)
8 INFLUENZA VIRUS VACCINE (H1N1) MARKET SALES BY REGION
8.1 Global Influenza Virus Vaccine (H1N1) Sales by Region
8.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Region
8.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region
8.2 Global Influenza Virus Vaccine (H1N1) Market Size by Region
8.2.1 Global Influenza Virus Vaccine (H1N1) Market Size by Region
8.2.2 Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Region
8.3 North America
8.3.1 North America Influenza Virus Vaccine (H1N1) Sales by Country
8.3.2 North America Influenza Virus Vaccine (H1N1) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country
8.4.2 Europe Influenza Virus Vaccine (H1N1) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region
8.5.2 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Influenza Virus Vaccine (H1N1) Sales by Country
8.6.2 South America Influenza Virus Vaccine (H1N1) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Region
8.7.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFLUENZA VIRUS VACCINE (H1N1) MARKET PRODUCTION BY REGION
9.1 Global Production of Influenza Virus Vaccine (H1N1) by Region(2020-2025)
9.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2020-2025)
9.3 Global Influenza Virus Vaccine (H1N1) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Influenza Virus Vaccine (H1N1) Production
9.4.1 North America Influenza Virus Vaccine (H1N1) Production Growth Rate (2020-2025)
9.4.2 North America Influenza Virus Vaccine (H1N1) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Influenza Virus Vaccine (H1N1) Production
9.5.1 Europe Influenza Virus Vaccine (H1N1) Production Growth Rate (2020-2025)
9.5.2 Europe Influenza Virus Vaccine (H1N1) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Influenza Virus Vaccine (H1N1) Production (2020-2025)
9.6.1 Japan Influenza Virus Vaccine (H1N1) Production Growth Rate (2020-2025)
9.6.2 Japan Influenza Virus Vaccine (H1N1) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Influenza Virus Vaccine (H1N1) Production (2020-2025)
9.7.1 China Influenza Virus Vaccine (H1N1) Production Growth Rate (2020-2025)
9.7.2 China Influenza Virus Vaccine (H1N1) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL
10.1.1 CSL Basic Information
10.1.2 CSL Influenza Virus Vaccine (H1N1) Product Overview
10.1.3 CSL Influenza Virus Vaccine (H1N1) Product Market Performance
10.1.4 CSL Business Overview
10.1.5 CSL SWOT Analysis
10.1.6 CSL Recent Developments
10.2 NVS(Novartis)
10.2.1 NVS(Novartis) Basic Information
10.2.2 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Overview
10.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Market Performance
10.2.4 NVS(Novartis) Business Overview
10.2.5 NVS(Novartis) SWOT Analysis
10.2.6 NVS(Novartis) Recent Developments
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Basic Information
10.3.2 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Overview
10.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Market Performance
10.3.4 Sanofi Pasteur Business Overview
10.3.5 Sanofi Pasteur SWOT Analysis
10.3.6 Sanofi Pasteur Recent Developments
10.4 Medimmune
10.4.1 Medimmune Basic Information
10.4.2 Medimmune Influenza Virus Vaccine (H1N1) Product Overview
10.4.3 Medimmune Influenza Virus Vaccine (H1N1) Product Market Performance
10.4.4 Medimmune Business Overview
10.4.5 Medimmune Recent Developments
10.5 GSK
10.5.1 GSK Basic Information
10.5.2 GSK Influenza Virus Vaccine (H1N1) Product Overview
10.5.3 GSK Influenza Virus Vaccine (H1N1) Product Market Performance
10.5.4 GSK Business Overview
10.5.5 GSK Recent Developments
10.6 Baxter
10.6.1 Baxter Basic Information
10.6.2 Baxter Influenza Virus Vaccine (H1N1) Product Overview
10.6.3 Baxter Influenza Virus Vaccine (H1N1) Product Market Performance
10.6.4 Baxter Business Overview
10.6.5 Baxter Recent Developments
10.7 Beijing Kexing Bio-Vaccine
10.7.1 Beijing Kexing Bio-Vaccine Basic Information
10.7.2 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Overview
10.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Market Performance
10.7.4 Beijing Kexing Bio-Vaccine Business Overview
10.7.5 Beijing Kexing Bio-Vaccine Recent Developments
10.8 Hualan Bio-Vaccine
10.8.1 Hualan Bio-Vaccine Basic Information
10.8.2 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Overview
10.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Market Performance
10.8.4 Hualan Bio-Vaccine Business Overview
10.8.5 Hualan Bio-Vaccine Recent Developments
10.9 Changchun Changsheng Bio-Technology
10.9.1 Changchun Changsheng Bio-Technology Basic Information
10.9.2 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Overview
10.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Market Performance
10.9.4 Changchun Changsheng Bio-Technology Business Overview
10.9.5 Changchun Changsheng Bio-Technology Recent Developments
10.10 Beijing Tiantan Bio-Products
10.10.1 Beijing Tiantan Bio-Products Basic Information
10.10.2 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Overview
10.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Market Performance
10.10.4 Beijing Tiantan Bio-Products Business Overview
10.10.5 Beijing Tiantan Bio-Products Recent Developments
10.11 Jiangsu Yanshen Bio-Technology
10.11.1 Jiangsu Yanshen Bio-Technology Basic Information
10.11.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Overview
10.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Market Performance
10.11.4 Jiangsu Yanshen Bio-Technology Business Overview
10.11.5 Jiangsu Yanshen Bio-Technology Recent Developments
10.12 Zhejiang Tianyuan Bio-Pharmaceutical
10.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Basic Information
10.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Overview
10.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Market Performance
10.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Business Overview
10.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
10.13 Dalian Yalifeng Bio-Pharmaceutical
10.13.1 Dalian Yalifeng Bio-Pharmaceutical Basic Information
10.13.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Overview
10.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Market Performance
10.13.4 Dalian Yalifeng Bio-Pharmaceutical Business Overview
10.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Developments
10.14 Sinopharm
10.14.1 Sinopharm Basic Information
10.14.2 Sinopharm Influenza Virus Vaccine (H1N1) Product Overview
10.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Product Market Performance
10.14.4 Sinopharm Business Overview
10.14.5 Sinopharm Recent Developments
11 INFLUENZA VIRUS VACCINE (H1N1) MARKET FORECAST BY REGION
11.1 Global Influenza Virus Vaccine (H1N1) Market Size Forecast
11.2 Global Influenza Virus Vaccine (H1N1) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Influenza Virus Vaccine (H1N1) Market Size Forecast by Country
11.2.3 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size Forecast by Region
11.2.4 South America Influenza Virus Vaccine (H1N1) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Influenza Virus Vaccine (H1N1) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Influenza Virus Vaccine (H1N1) Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Type (2026-2033)
12.1.2 Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Influenza Virus Vaccine (H1N1) by Type (2026-2033)
12.2 Global Influenza Virus Vaccine (H1N1) Market Forecast by Application (2026-2033)
12.2.1 Global Influenza Virus Vaccine (H1N1) Sales (K MT) Forecast by Application
12.2.2 Global Influenza Virus Vaccine (H1N1) Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Influenza Virus Vaccine (H1N1)
1.2 Key Market Segments
1.2.1 Influenza Virus Vaccine (H1N1) Segment by Type
1.2.2 Influenza Virus Vaccine (H1N1) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA VIRUS VACCINE (H1N1) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Virus Vaccine (H1N1) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Influenza Virus Vaccine (H1N1) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA VIRUS VACCINE (H1N1) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Influenza Virus Vaccine (H1N1) Product Life Cycle
3.3 Global Influenza Virus Vaccine (H1N1) Sales by Manufacturers (2020-2025)
3.4 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza Virus Vaccine (H1N1) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Influenza Virus Vaccine (H1N1) Market Competitive Situation and Trends
3.8.1 Influenza Virus Vaccine (H1N1) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza Virus Vaccine (H1N1) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFLUENZA VIRUS VACCINE (H1N1) INDUSTRY CHAIN ANALYSIS
4.1 Influenza Virus Vaccine (H1N1) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA VIRUS VACCINE (H1N1) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza Virus Vaccine (H1N1) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Influenza Virus Vaccine (H1N1) Market
5.7 ESG Ratings of Leading Companies
6 INFLUENZA VIRUS VACCINE (H1N1) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2020-2025)
6.3 Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Type (2020-2025)
6.4 Global Influenza Virus Vaccine (H1N1) Price by Type (2020-2025)
7 INFLUENZA VIRUS VACCINE (H1N1) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Virus Vaccine (H1N1) Market Sales by Application (2020-2025)
7.3 Global Influenza Virus Vaccine (H1N1) Market Size (M USD) by Application (2020-2025)
7.4 Global Influenza Virus Vaccine (H1N1) Sales Growth Rate by Application (2020-2025)
8 INFLUENZA VIRUS VACCINE (H1N1) MARKET SALES BY REGION
8.1 Global Influenza Virus Vaccine (H1N1) Sales by Region
8.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Region
8.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region
8.2 Global Influenza Virus Vaccine (H1N1) Market Size by Region
8.2.1 Global Influenza Virus Vaccine (H1N1) Market Size by Region
8.2.2 Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Region
8.3 North America
8.3.1 North America Influenza Virus Vaccine (H1N1) Sales by Country
8.3.2 North America Influenza Virus Vaccine (H1N1) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country
8.4.2 Europe Influenza Virus Vaccine (H1N1) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region
8.5.2 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Influenza Virus Vaccine (H1N1) Sales by Country
8.6.2 South America Influenza Virus Vaccine (H1N1) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Region
8.7.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFLUENZA VIRUS VACCINE (H1N1) MARKET PRODUCTION BY REGION
9.1 Global Production of Influenza Virus Vaccine (H1N1) by Region(2020-2025)
9.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2020-2025)
9.3 Global Influenza Virus Vaccine (H1N1) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Influenza Virus Vaccine (H1N1) Production
9.4.1 North America Influenza Virus Vaccine (H1N1) Production Growth Rate (2020-2025)
9.4.2 North America Influenza Virus Vaccine (H1N1) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Influenza Virus Vaccine (H1N1) Production
9.5.1 Europe Influenza Virus Vaccine (H1N1) Production Growth Rate (2020-2025)
9.5.2 Europe Influenza Virus Vaccine (H1N1) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Influenza Virus Vaccine (H1N1) Production (2020-2025)
9.6.1 Japan Influenza Virus Vaccine (H1N1) Production Growth Rate (2020-2025)
9.6.2 Japan Influenza Virus Vaccine (H1N1) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Influenza Virus Vaccine (H1N1) Production (2020-2025)
9.7.1 China Influenza Virus Vaccine (H1N1) Production Growth Rate (2020-2025)
9.7.2 China Influenza Virus Vaccine (H1N1) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL
10.1.1 CSL Basic Information
10.1.2 CSL Influenza Virus Vaccine (H1N1) Product Overview
10.1.3 CSL Influenza Virus Vaccine (H1N1) Product Market Performance
10.1.4 CSL Business Overview
10.1.5 CSL SWOT Analysis
10.1.6 CSL Recent Developments
10.2 NVS(Novartis)
10.2.1 NVS(Novartis) Basic Information
10.2.2 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Overview
10.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Market Performance
10.2.4 NVS(Novartis) Business Overview
10.2.5 NVS(Novartis) SWOT Analysis
10.2.6 NVS(Novartis) Recent Developments
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Basic Information
10.3.2 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Overview
10.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Market Performance
10.3.4 Sanofi Pasteur Business Overview
10.3.5 Sanofi Pasteur SWOT Analysis
10.3.6 Sanofi Pasteur Recent Developments
10.4 Medimmune
10.4.1 Medimmune Basic Information
10.4.2 Medimmune Influenza Virus Vaccine (H1N1) Product Overview
10.4.3 Medimmune Influenza Virus Vaccine (H1N1) Product Market Performance
10.4.4 Medimmune Business Overview
10.4.5 Medimmune Recent Developments
10.5 GSK
10.5.1 GSK Basic Information
10.5.2 GSK Influenza Virus Vaccine (H1N1) Product Overview
10.5.3 GSK Influenza Virus Vaccine (H1N1) Product Market Performance
10.5.4 GSK Business Overview
10.5.5 GSK Recent Developments
10.6 Baxter
10.6.1 Baxter Basic Information
10.6.2 Baxter Influenza Virus Vaccine (H1N1) Product Overview
10.6.3 Baxter Influenza Virus Vaccine (H1N1) Product Market Performance
10.6.4 Baxter Business Overview
10.6.5 Baxter Recent Developments
10.7 Beijing Kexing Bio-Vaccine
10.7.1 Beijing Kexing Bio-Vaccine Basic Information
10.7.2 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Overview
10.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Market Performance
10.7.4 Beijing Kexing Bio-Vaccine Business Overview
10.7.5 Beijing Kexing Bio-Vaccine Recent Developments
10.8 Hualan Bio-Vaccine
10.8.1 Hualan Bio-Vaccine Basic Information
10.8.2 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Overview
10.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Market Performance
10.8.4 Hualan Bio-Vaccine Business Overview
10.8.5 Hualan Bio-Vaccine Recent Developments
10.9 Changchun Changsheng Bio-Technology
10.9.1 Changchun Changsheng Bio-Technology Basic Information
10.9.2 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Overview
10.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Market Performance
10.9.4 Changchun Changsheng Bio-Technology Business Overview
10.9.5 Changchun Changsheng Bio-Technology Recent Developments
10.10 Beijing Tiantan Bio-Products
10.10.1 Beijing Tiantan Bio-Products Basic Information
10.10.2 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Overview
10.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Market Performance
10.10.4 Beijing Tiantan Bio-Products Business Overview
10.10.5 Beijing Tiantan Bio-Products Recent Developments
10.11 Jiangsu Yanshen Bio-Technology
10.11.1 Jiangsu Yanshen Bio-Technology Basic Information
10.11.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Overview
10.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Market Performance
10.11.4 Jiangsu Yanshen Bio-Technology Business Overview
10.11.5 Jiangsu Yanshen Bio-Technology Recent Developments
10.12 Zhejiang Tianyuan Bio-Pharmaceutical
10.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Basic Information
10.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Overview
10.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Market Performance
10.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Business Overview
10.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
10.13 Dalian Yalifeng Bio-Pharmaceutical
10.13.1 Dalian Yalifeng Bio-Pharmaceutical Basic Information
10.13.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Overview
10.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Market Performance
10.13.4 Dalian Yalifeng Bio-Pharmaceutical Business Overview
10.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Developments
10.14 Sinopharm
10.14.1 Sinopharm Basic Information
10.14.2 Sinopharm Influenza Virus Vaccine (H1N1) Product Overview
10.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Product Market Performance
10.14.4 Sinopharm Business Overview
10.14.5 Sinopharm Recent Developments
11 INFLUENZA VIRUS VACCINE (H1N1) MARKET FORECAST BY REGION
11.1 Global Influenza Virus Vaccine (H1N1) Market Size Forecast
11.2 Global Influenza Virus Vaccine (H1N1) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Influenza Virus Vaccine (H1N1) Market Size Forecast by Country
11.2.3 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size Forecast by Region
11.2.4 South America Influenza Virus Vaccine (H1N1) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Influenza Virus Vaccine (H1N1) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Influenza Virus Vaccine (H1N1) Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Type (2026-2033)
12.1.2 Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Influenza Virus Vaccine (H1N1) by Type (2026-2033)
12.2 Global Influenza Virus Vaccine (H1N1) Market Forecast by Application (2026-2033)
12.2.1 Global Influenza Virus Vaccine (H1N1) Sales (K MT) Forecast by Application
12.2.2 Global Influenza Virus Vaccine (H1N1) Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Virus Vaccine (H1N1) Market Size Comparison by Region (M USD)
Table 5. Global Influenza Virus Vaccine (H1N1) Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Influenza Virus Vaccine (H1N1) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2024)
Table 10. Global Market Influenza Virus Vaccine (H1N1) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Influenza Virus Vaccine (H1N1) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Influenza Virus Vaccine (H1N1) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Influenza Virus Vaccine (H1N1) Sales by Type (K MT)
Table 26. Global Influenza Virus Vaccine (H1N1) Market Size by Type (M USD)
Table 27. Global Influenza Virus Vaccine (H1N1) Sales (K MT) by Type (2020-2025)
Table 28. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2020-2025)
Table 29. Global Influenza Virus Vaccine (H1N1) Market Size (M USD) by Type (2020-2025)
Table 30. Global Influenza Virus Vaccine (H1N1) Market Size Share by Type (2020-2025)
Table 31. Global Influenza Virus Vaccine (H1N1) Price (USD/KG) by Type (2020-2025)
Table 32. Global Influenza Virus Vaccine (H1N1) Sales (K MT) by Application
Table 33. Global Influenza Virus Vaccine (H1N1) Market Size by Application
Table 34. Global Influenza Virus Vaccine (H1N1) Sales by Application (2020-2025) & (K MT)
Table 35. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2020-2025)
Table 36. Global Influenza Virus Vaccine (H1N1) Market Size by Application (2020-2025) & (M USD)
Table 37. Global Influenza Virus Vaccine (H1N1) Market Share by Application (2020-2025)
Table 38. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate by Application (2020-2025)
Table 39. Global Influenza Virus Vaccine (H1N1) Sales by Region (2020-2025) & (K MT)
Table 40. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2020-2025)
Table 41. Global Influenza Virus Vaccine (H1N1) Market Size by Region (2020-2025) & (M USD)
Table 42. Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Region (2020-2025)
Table 43. North America Influenza Virus Vaccine (H1N1) Sales by Country (2020-2025) & (K MT)
Table 44. North America Influenza Virus Vaccine (H1N1) Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2020-2025) & (K MT)
Table 46. Europe Influenza Virus Vaccine (H1N1) Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Influenza Virus Vaccine (H1N1) Market Size by Region (2020-2025) & (M USD)
Table 49. South America Influenza Virus Vaccine (H1N1) Sales by Country (2020-2025) & (K MT)
Table 50. South America Influenza Virus Vaccine (H1N1) Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size by Region (2020-2025) & (M USD)
Table 53. Global Influenza Virus Vaccine (H1N1) Production (K MT) by Region(2020-2025)
Table 54. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2020-2025)
Table 56. Global Influenza Virus Vaccine (H1N1) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Influenza Virus Vaccine (H1N1) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Influenza Virus Vaccine (H1N1) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Influenza Virus Vaccine (H1N1) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Influenza Virus Vaccine (H1N1) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. CSL Basic Information
Table 62. CSL Influenza Virus Vaccine (H1N1) Product Overview
Table 63. CSL Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. CSL Business Overview
Table 65. CSL SWOT Analysis
Table 66. CSL Recent Developments
Table 67. NVS(Novartis) Basic Information
Table 68. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Overview
Table 69. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. NVS(Novartis) Business Overview
Table 71. NVS(Novartis) SWOT Analysis
Table 72. NVS(Novartis) Recent Developments
Table 73. Sanofi Pasteur Basic Information
Table 74. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Overview
Table 75. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Sanofi Pasteur Business Overview
Table 77. Sanofi Pasteur SWOT Analysis
Table 78. Sanofi Pasteur Recent Developments
Table 79. Medimmune Basic Information
Table 80. Medimmune Influenza Virus Vaccine (H1N1) Product Overview
Table 81. Medimmune Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Medimmune Business Overview
Table 83. Medimmune Recent Developments
Table 84. GSK Basic Information
Table 85. GSK Influenza Virus Vaccine (H1N1) Product Overview
Table 86. GSK Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. GSK Business Overview
Table 88. GSK Recent Developments
Table 89. Baxter Basic Information
Table 90. Baxter Influenza Virus Vaccine (H1N1) Product Overview
Table 91. Baxter Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Baxter Business Overview
Table 93. Baxter Recent Developments
Table 94. Beijing Kexing Bio-Vaccine Basic Information
Table 95. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Overview
Table 96. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Beijing Kexing Bio-Vaccine Business Overview
Table 98. Beijing Kexing Bio-Vaccine Recent Developments
Table 99. Hualan Bio-Vaccine Basic Information
Table 100. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Overview
Table 101. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Hualan Bio-Vaccine Business Overview
Table 103. Hualan Bio-Vaccine Recent Developments
Table 104. Changchun Changsheng Bio-Technology Basic Information
Table 105. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Overview
Table 106. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Changchun Changsheng Bio-Technology Business Overview
Table 108. Changchun Changsheng Bio-Technology Recent Developments
Table 109. Beijing Tiantan Bio-Products Basic Information
Table 110. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Overview
Table 111. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Beijing Tiantan Bio-Products Business Overview
Table 113. Beijing Tiantan Bio-Products Recent Developments
Table 114. Jiangsu Yanshen Bio-Technology Basic Information
Table 115. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Overview
Table 116. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Jiangsu Yanshen Bio-Technology Business Overview
Table 118. Jiangsu Yanshen Bio-Technology Recent Developments
Table 119. Zhejiang Tianyuan Bio-Pharmaceutical Basic Information
Table 120. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Overview
Table 121. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Zhejiang Tianyuan Bio-Pharmaceutical Business Overview
Table 123. Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
Table 124. Dalian Yalifeng Bio-Pharmaceutical Basic Information
Table 125. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Overview
Table 126. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Dalian Yalifeng Bio-Pharmaceutical Business Overview
Table 128. Dalian Yalifeng Bio-Pharmaceutical Recent Developments
Table 129. Sinopharm Basic Information
Table 130. Sinopharm Influenza Virus Vaccine (H1N1) Product Overview
Table 131. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Sinopharm Business Overview
Table 133. Sinopharm Recent Developments
Table 134. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2026-2033) & (K MT)
Table 135. Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. North America Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2026-2033) & (K MT)
Table 137. North America Influenza Virus Vaccine (H1N1) Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Europe Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2026-2033) & (K MT)
Table 139. Europe Influenza Virus Vaccine (H1N1) Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2026-2033) & (K MT)
Table 141. Asia Pacific Influenza Virus Vaccine (H1N1) Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2026-2033) & (K MT)
Table 143. South America Influenza Virus Vaccine (H1N1) Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2026-2033) & (Units)
Table 145. Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size Forecast by Country (2026-2033) & (M USD)
Table 146. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2026-2033) & (K MT)
Table 147. Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Type (2026-2033) & (M USD)
Table 148. Global Influenza Virus Vaccine (H1N1) Price Forecast by Type (2026-2033) & (USD/KG)
Table 149. Global Influenza Virus Vaccine (H1N1) Sales (K MT) Forecast by Application (2026-2033)
Table 150. Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Virus Vaccine (H1N1) Market Size Comparison by Region (M USD)
Table 5. Global Influenza Virus Vaccine (H1N1) Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Influenza Virus Vaccine (H1N1) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2024)
Table 10. Global Market Influenza Virus Vaccine (H1N1) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Influenza Virus Vaccine (H1N1) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Influenza Virus Vaccine (H1N1) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Influenza Virus Vaccine (H1N1) Sales by Type (K MT)
Table 26. Global Influenza Virus Vaccine (H1N1) Market Size by Type (M USD)
Table 27. Global Influenza Virus Vaccine (H1N1) Sales (K MT) by Type (2020-2025)
Table 28. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2020-2025)
Table 29. Global Influenza Virus Vaccine (H1N1) Market Size (M USD) by Type (2020-2025)
Table 30. Global Influenza Virus Vaccine (H1N1) Market Size Share by Type (2020-2025)
Table 31. Global Influenza Virus Vaccine (H1N1) Price (USD/KG) by Type (2020-2025)
Table 32. Global Influenza Virus Vaccine (H1N1) Sales (K MT) by Application
Table 33. Global Influenza Virus Vaccine (H1N1) Market Size by Application
Table 34. Global Influenza Virus Vaccine (H1N1) Sales by Application (2020-2025) & (K MT)
Table 35. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2020-2025)
Table 36. Global Influenza Virus Vaccine (H1N1) Market Size by Application (2020-2025) & (M USD)
Table 37. Global Influenza Virus Vaccine (H1N1) Market Share by Application (2020-2025)
Table 38. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate by Application (2020-2025)
Table 39. Global Influenza Virus Vaccine (H1N1) Sales by Region (2020-2025) & (K MT)
Table 40. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2020-2025)
Table 41. Global Influenza Virus Vaccine (H1N1) Market Size by Region (2020-2025) & (M USD)
Table 42. Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Region (2020-2025)
Table 43. North America Influenza Virus Vaccine (H1N1) Sales by Country (2020-2025) & (K MT)
Table 44. North America Influenza Virus Vaccine (H1N1) Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2020-2025) & (K MT)
Table 46. Europe Influenza Virus Vaccine (H1N1) Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Influenza Virus Vaccine (H1N1) Market Size by Region (2020-2025) & (M USD)
Table 49. South America Influenza Virus Vaccine (H1N1) Sales by Country (2020-2025) & (K MT)
Table 50. South America Influenza Virus Vaccine (H1N1) Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size by Region (2020-2025) & (M USD)
Table 53. Global Influenza Virus Vaccine (H1N1) Production (K MT) by Region(2020-2025)
Table 54. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2020-2025)
Table 56. Global Influenza Virus Vaccine (H1N1) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Influenza Virus Vaccine (H1N1) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Influenza Virus Vaccine (H1N1) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Influenza Virus Vaccine (H1N1) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Influenza Virus Vaccine (H1N1) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. CSL Basic Information
Table 62. CSL Influenza Virus Vaccine (H1N1) Product Overview
Table 63. CSL Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. CSL Business Overview
Table 65. CSL SWOT Analysis
Table 66. CSL Recent Developments
Table 67. NVS(Novartis) Basic Information
Table 68. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Overview
Table 69. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. NVS(Novartis) Business Overview
Table 71. NVS(Novartis) SWOT Analysis
Table 72. NVS(Novartis) Recent Developments
Table 73. Sanofi Pasteur Basic Information
Table 74. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Overview
Table 75. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Sanofi Pasteur Business Overview
Table 77. Sanofi Pasteur SWOT Analysis
Table 78. Sanofi Pasteur Recent Developments
Table 79. Medimmune Basic Information
Table 80. Medimmune Influenza Virus Vaccine (H1N1) Product Overview
Table 81. Medimmune Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Medimmune Business Overview
Table 83. Medimmune Recent Developments
Table 84. GSK Basic Information
Table 85. GSK Influenza Virus Vaccine (H1N1) Product Overview
Table 86. GSK Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. GSK Business Overview
Table 88. GSK Recent Developments
Table 89. Baxter Basic Information
Table 90. Baxter Influenza Virus Vaccine (H1N1) Product Overview
Table 91. Baxter Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Baxter Business Overview
Table 93. Baxter Recent Developments
Table 94. Beijing Kexing Bio-Vaccine Basic Information
Table 95. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Overview
Table 96. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Beijing Kexing Bio-Vaccine Business Overview
Table 98. Beijing Kexing Bio-Vaccine Recent Developments
Table 99. Hualan Bio-Vaccine Basic Information
Table 100. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Overview
Table 101. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Hualan Bio-Vaccine Business Overview
Table 103. Hualan Bio-Vaccine Recent Developments
Table 104. Changchun Changsheng Bio-Technology Basic Information
Table 105. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Overview
Table 106. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Changchun Changsheng Bio-Technology Business Overview
Table 108. Changchun Changsheng Bio-Technology Recent Developments
Table 109. Beijing Tiantan Bio-Products Basic Information
Table 110. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Overview
Table 111. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Beijing Tiantan Bio-Products Business Overview
Table 113. Beijing Tiantan Bio-Products Recent Developments
Table 114. Jiangsu Yanshen Bio-Technology Basic Information
Table 115. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Overview
Table 116. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Jiangsu Yanshen Bio-Technology Business Overview
Table 118. Jiangsu Yanshen Bio-Technology Recent Developments
Table 119. Zhejiang Tianyuan Bio-Pharmaceutical Basic Information
Table 120. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Overview
Table 121. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Zhejiang Tianyuan Bio-Pharmaceutical Business Overview
Table 123. Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
Table 124. Dalian Yalifeng Bio-Pharmaceutical Basic Information
Table 125. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Overview
Table 126. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Dalian Yalifeng Bio-Pharmaceutical Business Overview
Table 128. Dalian Yalifeng Bio-Pharmaceutical Recent Developments
Table 129. Sinopharm Basic Information
Table 130. Sinopharm Influenza Virus Vaccine (H1N1) Product Overview
Table 131. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Sinopharm Business Overview
Table 133. Sinopharm Recent Developments
Table 134. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2026-2033) & (K MT)
Table 135. Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. North America Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2026-2033) & (K MT)
Table 137. North America Influenza Virus Vaccine (H1N1) Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Europe Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2026-2033) & (K MT)
Table 139. Europe Influenza Virus Vaccine (H1N1) Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2026-2033) & (K MT)
Table 141. Asia Pacific Influenza Virus Vaccine (H1N1) Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2026-2033) & (K MT)
Table 143. South America Influenza Virus Vaccine (H1N1) Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2026-2033) & (Units)
Table 145. Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size Forecast by Country (2026-2033) & (M USD)
Table 146. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2026-2033) & (K MT)
Table 147. Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Type (2026-2033) & (M USD)
Table 148. Global Influenza Virus Vaccine (H1N1) Price Forecast by Type (2026-2033) & (USD/KG)
Table 149. Global Influenza Virus Vaccine (H1N1) Sales (K MT) Forecast by Application (2026-2033)
Table 150. Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Influenza Virus Vaccine (H1N1)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Virus Vaccine (H1N1) Market Size (M USD), 2024-2033
Figure 5. Global Influenza Virus Vaccine (H1N1) Market Size (M USD) (2020-2033)
Figure 6. Global Influenza Virus Vaccine (H1N1) Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Virus Vaccine (H1N1) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza Virus Vaccine (H1N1) Product Life Cycle
Figure 13. Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers in 2024
Figure 14. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers in 2024
Figure 15. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Influenza Virus Vaccine (H1N1) Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza Virus Vaccine (H1N1) Revenue in 2024
Figure 18. Industry Chain Map of Influenza Virus Vaccine (H1N1)
Figure 19. Global Influenza Virus Vaccine (H1N1) Market PEST Analysis
Figure 20. Global Influenza Virus Vaccine (H1N1) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Influenza Virus Vaccine (H1N1) Market Share by Type
Figure 27. Sales Market Share of Influenza Virus Vaccine (H1N1) by Type (2020-2025)
Figure 28. Sales Market Share of Influenza Virus Vaccine (H1N1) by Type in 2024
Figure 29. Market Size Share of Influenza Virus Vaccine (H1N1) by Type (2020-2025)
Figure 30. Market Size Share of Influenza Virus Vaccine (H1N1) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Influenza Virus Vaccine (H1N1) Market Share by Application
Figure 33. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2020-2025)
Figure 34. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2024
Figure 35. Global Influenza Virus Vaccine (H1N1) Market Share by Application (2020-2025)
Figure 36. Global Influenza Virus Vaccine (H1N1) Market Share by Application in 2024
Figure 37. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2020-2025)
Figure 39. Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Region (2020-2025)
Figure 40. North America Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2024
Figure 43. North America Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Influenza Virus Vaccine (H1N1) Market Size Market Share by Country in 2024
Figure 45. U.S. Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Influenza Virus Vaccine (H1N1) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Influenza Virus Vaccine (H1N1) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Influenza Virus Vaccine (H1N1) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Influenza Virus Vaccine (H1N1) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2024
Figure 53. Europe Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Influenza Virus Vaccine (H1N1) Market Size Market Share by Country in 2024
Figure 55. Germany Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Influenza Virus Vaccine (H1N1) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Influenza Virus Vaccine (H1N1) Market Size Market Share by Region in 2024
Figure 68. China Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Influenza Virus Vaccine (H1N1) Sales and Growth Rate (K MT)
Figure 79. South America Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2024
Figure 80. South America Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (M USD)
Figure 81. South America Influenza Virus Vaccine (H1N1) Market Size Market Share by Country in 2024
Figure 82. Brazil Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Influenza Virus Vaccine (H1N1) Production Market Share by Region (2020-2025)
Figure 103. North America Influenza Virus Vaccine (H1N1) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Influenza Virus Vaccine (H1N1) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Influenza Virus Vaccine (H1N1) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Influenza Virus Vaccine (H1N1) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Influenza Virus Vaccine (H1N1) Market Share Forecast by Type (2026-2033)
Figure 111. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2026-2033)
Figure 112. Global Influenza Virus Vaccine (H1N1) Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Influenza Virus Vaccine (H1N1)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Virus Vaccine (H1N1) Market Size (M USD), 2024-2033
Figure 5. Global Influenza Virus Vaccine (H1N1) Market Size (M USD) (2020-2033)
Figure 6. Global Influenza Virus Vaccine (H1N1) Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Virus Vaccine (H1N1) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza Virus Vaccine (H1N1) Product Life Cycle
Figure 13. Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers in 2024
Figure 14. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers in 2024
Figure 15. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Influenza Virus Vaccine (H1N1) Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza Virus Vaccine (H1N1) Revenue in 2024
Figure 18. Industry Chain Map of Influenza Virus Vaccine (H1N1)
Figure 19. Global Influenza Virus Vaccine (H1N1) Market PEST Analysis
Figure 20. Global Influenza Virus Vaccine (H1N1) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Influenza Virus Vaccine (H1N1) Market Share by Type
Figure 27. Sales Market Share of Influenza Virus Vaccine (H1N1) by Type (2020-2025)
Figure 28. Sales Market Share of Influenza Virus Vaccine (H1N1) by Type in 2024
Figure 29. Market Size Share of Influenza Virus Vaccine (H1N1) by Type (2020-2025)
Figure 30. Market Size Share of Influenza Virus Vaccine (H1N1) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Influenza Virus Vaccine (H1N1) Market Share by Application
Figure 33. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2020-2025)
Figure 34. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2024
Figure 35. Global Influenza Virus Vaccine (H1N1) Market Share by Application (2020-2025)
Figure 36. Global Influenza Virus Vaccine (H1N1) Market Share by Application in 2024
Figure 37. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2020-2025)
Figure 39. Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Region (2020-2025)
Figure 40. North America Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2024
Figure 43. North America Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Influenza Virus Vaccine (H1N1) Market Size Market Share by Country in 2024
Figure 45. U.S. Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Influenza Virus Vaccine (H1N1) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Influenza Virus Vaccine (H1N1) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Influenza Virus Vaccine (H1N1) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Influenza Virus Vaccine (H1N1) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2024
Figure 53. Europe Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Influenza Virus Vaccine (H1N1) Market Size Market Share by Country in 2024
Figure 55. Germany Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Influenza Virus Vaccine (H1N1) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Influenza Virus Vaccine (H1N1) Market Size Market Share by Region in 2024
Figure 68. China Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Influenza Virus Vaccine (H1N1) Sales and Growth Rate (K MT)
Figure 79. South America Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2024
Figure 80. South America Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (M USD)
Figure 81. South America Influenza Virus Vaccine (H1N1) Market Size Market Share by Country in 2024
Figure 82. Brazil Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Influenza Virus Vaccine (H1N1) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Influenza Virus Vaccine (H1N1) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Influenza Virus Vaccine (H1N1) Production Market Share by Region (2020-2025)
Figure 103. North America Influenza Virus Vaccine (H1N1) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Influenza Virus Vaccine (H1N1) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Influenza Virus Vaccine (H1N1) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Influenza Virus Vaccine (H1N1) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Influenza Virus Vaccine (H1N1) Market Share Forecast by Type (2026-2033)
Figure 111. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2026-2033)
Figure 112. Global Influenza Virus Vaccine (H1N1) Market Share Forecast by Application (2026-2033)
